Magnesium%25252525252525252525252525252525252525252525252525252520sulfate

# Magnesium Sulfate ## Overview Magnesium sulfate is an essential mineral that plays a vital role in various physiological processes, including neuromuscular function, cardiac rhythm, and enzyme activity. It is available in intravenous (IV) and intramuscular (IM) formulations. ## Primary Indications * Hypomagnesemia * Eclampsia and preeclampsia * Torsades de pointes * Bronchodilator in acute asthma exacerbations (adjunctive therapy) * Constipation (oral formulation, less commonly used for acute needs) ## Adult Dosing * **Hypomagnesemia:** * **Severe:** 4 to 6 g IV infusion over 5 to 60 minutes, followed by a maintenance infusion of 1 to 2 g/hour. Alternatively, 1 to 2 g IM every 4 hours for 4 doses. Dosing may be guided by serum magnesium levels and ongoing losses, with total daily doses potentially exceeding 30 g. * **Less severe:** 2 to 4 g IV infusion over 5 to 60 minutes. * **Eclampsia/Preeclampsia:** * **Loading Dose:** 4 to 6 g IV infusion over 5 minutes, followed by a continuous IV infusion of 1 to 2 g/hour. * **Alternative IM Dosing:** 5 g IM in each buttock (10 g total) for the loading dose, followed by 5 g IM to alternate buttocks every 4 hours. * **Torsades de Pointes:** 1 to 2 g IV in 10 mL of D5W over 5 to 10 minutes. May be followed by a continuous infusion of 0.5 to 1 g/hour. * **Acute Asthma Exacerbation:** 1.2 to 2 g IV infusion over 15 to 30 minutes. *Note: Dosing for hypomagnesemia, particularly replacement therapy, is often guided by specific protocols and serum magnesium levels.* ## Pediatric Dosing * **Hypomagnesemia:** * Dosing varies widely based on age, weight, and severity. Commonly cited doses include: * **Neonates:** 25 to 50 mg/kg/dose IV every 8 to 12 hours. * **Older Children:** 20 to 50 mg/kg/dose IV every 4 to 6 hours. * Dosing is often guided by serum magnesium levels and may require doses up to 100 mg/kg/day. *Note: Pediatric dosing is complex and should be guided by established protocols and expert consultation.* ## Dose Adjustments * **Renal Impairment:** Magnesium sulfate is excreted by the kidneys. In patients with impaired renal function, magnesium reabsorption is reduced, increasing the risk of hypermagnesemia. Dosing should be reduced and serum magnesium levels closely monitored. ## Contraindications * Hypermagnesemia * Heart block * Myocardial infarction (in certain severe forms, caution is advised) * Renal failure (use with extreme caution and reduced doses) ## Adverse Effects * **Common:** Flushing, hypotension, nausea, vomiting, diarrhea, drowsiness, lethargy, decreased deep tendon reflexes. * **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (muscle weakness, decreased reflexes, hypotension, bradycardia, ECG changes, respiratory depression, asystole). ## Key Drug Interactions * **Neuromuscular Blocking Agents (e.g., rocuronium, succinylcholine):** Magnesium sulfate can potentiate neuromuscular blockade, leading to prolonged paralysis and respiratory depression. * **Calcium Channel Blockers:** Additive hypotensive effects and risk of bradycardia or heart block. * **Antibiotics (e.g., tetracyclines, quinolones):** Magnesium can chelate with these antibiotics, reducing their absorption. Separate administration by at least 2 hours. * **Bisphosphonates:** Magnesium can decrease absorption; separate administration by at least 2 hours. ## Monitoring * **Serum Magnesium Levels:** Essential for guiding dose adjustments and assessing efficacy, especially with chronic or high-dose therapy. Therapeutic range typically 1.7-2.2 mEq/L (0.7-0.9 mmol/L), but higher levels may be targeted in specific situations like eclampsia. * **Renal Function:** Monitor BUN and creatinine. * **Neurological Status:** Assess for deep tendon reflexes, mental status, and respiratory rate. * **Cardiac Status:** Monitor ECG and blood pressure. * **Urine Output:** Important indicator of renal function and adequacy of hydration. ## Clinical Pearls * When administering IV magnesium sulfate, always have calcium gluconate readily available as an antidote for severe hypermagnesemia. * Rapid IV infusion can cause flushing and hypotension. Infuse slowly as recommended. * Monitor for signs of hypermagnesemia, particularly in patients with impaired renal function. * In eclampsia, continued magnesium infusion post-delivery is often crucial for seizure prevention. * For acute asthma, consider it as adjunctive therapy alongside standard bronchodilators and steroids. --- *This information is intended for healthcare professionals. Always consult the most current prescribing information and institutional guidelines before making any treatment decisions.*